Dear CEBM listserv colleagues,
Building on the spirit of clinical trial data transparency, the
RxISK organization is running a very specific petition to help the global efforts on transparency.
RxISK and its growing supporters are calling AbbVie
and InterMune to drop their recent outrageous legal
action against the European Medicines Agency (EMA), where these two
companies defined drug hazards as "commercially confidential" information (!). I'm sure everyone on
the CEBM listserv is familiar with this huge transparency setback and
its consequences to global
patient safety and transparency initiatives. In case you'd like more
information, you can find it here and here.
Please read the recent JAMA letter by Peter Doshi (attached), detailing further this unfortunate backward step in transparency.
Anybody taking any kind of medication has a
right to know all about their medication. Drug hazards cannot be
defined as "trade secrets".
Please give your voice of support to the
RxISK initiative in its effort to stop the legal action against EMA and contribute to global patient safety and better medicines.
Please forward this email to anybody who would be interested in supporting global patient safety efforts.
Thank you for your support!
Sincerely,
--
Lejla Halilovic, BSc., Hon. O.C.G.C. (Pharm. Reg. Affairs)
e. [log in to unmask]LinkedIn. http://ca.linkedin.com/in/lejlahalilovic
